 | Up a level |
Parker, Christopher C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Hoyle, Alex P; Ali, Adnan; Ritchie, Alastair W S; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P; Gillessen, Silke; Gilson, Clare; Jones, Robert J; Langley, Ruth E; Malik, Zafar I; Mason, Malcolm D; Matheson, David; Millman, Robin; Russell, J Martin; ... (2018). Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet, 392(10162), pp. 2353-2366. Elsevier 10.1016/S0140-6736(18)32486-3
James, Nicholas David; Spears, Melissa R; Clarke, Noel W; Dearnaley, David P; De Bono, Johann S; Gale, Joanna; Hetherington, John; Hoskin, Peter J; Jones, Robert J; Laing, Robert; Lester, Jason F; McLaren, Duncan; Parker, Christopher C; Parmar, Mahesh K B; Ritchie, Alastair W S; Russell, J Martin; Strebel, Räto T; Thalmann, George; Mason, Malcolm D and Sydes, Matthew R (2015). Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019). European urology, 67(6), pp. 1028-1038. Elsevier 10.1016/j.eururo.2014.09.032
